ARTICLE | Company News
CFDA approves Canbridge's oral mucositis drug
April 26, 2018 12:03 PM UTC
Canbridge Life Sciences Ltd. (Beijing, China) said China FDA approved Caphosol (CAN002) to treat oral mucositis.
The company has Chinese rights to the supersaturated calcium phosphate rinse from EUSA Pharma Ltd. (Hemel Hempstead, U.K.). The company said the drug, which is approved in 47 other countries, is its first commercialized product. ...